Pharmidex will be attending the BBMS Gala Dinner 2026
January 21, 2026

We’re delighted to share that Vasudha Tandon, PhD Principal Scientist at Pharmidex, will be attending the BBMS Gala Dinner 2026 on Thursday 22 January 2026 at the Old Hall, Queens’ College, Cambridge.


This special evening, part of Building Bridges in Medical Sciences, brings together leaders from academia, industry, and healthcare to strengthen collaboration across the life sciences.


Vasudha is looking forward to meeting fellow attendees and exploring new opportunities to build meaningful scientific partnerships.

#Pharmidex #BBMS #BuildingBridges #MedicalSciences #Cambridge #Networking #Collaboration

April 20, 2026
Pharmidex is pleased to announce that Ian Knowles and Janette Dalay Robertson , will be attending TARGET TO PATIENT 2026 (T2P26) on Monday 20th – Tuesday 21st April 2026 at the Hinxton Hall Conference Centre, Wellcome Genome Campus, Cambridge, UK. They look forward to meeting founders, investors and biotech leaders to discuss drug discovery, translational partnerships and life science investment opportunities. Feel free to catch them for a chat!
FROM DISCOVERY TO DISTRIBUTION
April 16, 2026
Pharmidex is pleased to announce that Martin Barrett , Head of Business Development, will be attending FROM DISCOVERY TO DISTRIBUTION – Making Pharmaceuticals 2026 on 21–22 April 2026 at the Coventry Building Society Arena, UK. Martin looks forward to meeting pharma innovators, formulation scientists, manufacturing leaders and strategic partners to discuss drug discovery, development, translational science, and end-to-end pharmaceutical solutions. If you’re attending, feel free to stop by for a chat and explore how Pharmidex can support your programmes from discovery through development.
April 15, 2026
Pharmidex will be attending Swiss Biotech Day 2026 on 4–5 May 2026 at the Congress Center Basel, Switzerland. We look forward to meeting founders, investors, biotech leaders and scientific partners to discuss drug discovery, translational development and strategic R&D opportunities. Feel free to catch us for a chat!
More Posts